Bio-adaptable Implantable Sensor with Hydrophobic Membrane
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable glucose sensors face challenges such as limited sensitivity due to oxygen deficits, tissue response issues like foreign body reaction and fibrosis, and short-term functionality due to biocompatibility and diffusion limitations, leading to inaccurate and short-lived monitoring of blood glucose levels in diabetic patients.
Innovation Solution
A biocompatible, miniaturized implantable sensor with a non-enzymatic membrane and adaptive circuitry that promotes interlock with tissue without vascularization, using oxygen-based sensing elements and a hydrophobic outer membrane to restrict blood vessel ingrowth, ensuring stable glucose monitoring over extended periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a conventional implantable glucose sensor is used, then blood glucose monitoring is achieved, but tissue response such as foreign body reaction and fibrosis occurs leading to sensor encapsulation and failure
Solution Approach 1:
The patent changes the physical and chemical parameters of the sensor surface by coating it with hydrophilic polymers (such as polyethylene glycol or hydroxypropyl methylcellulose) to reduce protein adsorption and cellular adhesion. This parameter change in surface hydrophilicity and energy directly reduces the foreign body reaction and fibrosis formation, allowing the sensor to maintain reliability for extended periods.
Solution Approach 2:
The sensor employs composite material structures combining biocompatible materials (such as medical-grade stainless steel, titanium, or biocompatible polymers) with hydrophilic coating layers. This composite approach integrates the mechanical strength and electrical conductivity of the base material with the anti-fouling properties of the hydrophilic coating, resolving the contradiction between sensor functionality and tissue response.
2Duration of action of stationary object
If the sensor remains implanted for long-term monitoring, then extended glucose data is obtained, but sensor drift and signal degradation occur due to tissue encapsulation
Solution Approach 1:
The patent implements parameter changes in the sensor electrode properties, including using enzyme-free amperometric sensors with optimized electrode potentials and incorporating redox mediators. These parameter changes reduce oxygen dependency and improve signal stability over time, counteracting the degradation caused by tissue encapsulation and extending the functional implantation duration while maintaining measurement precision.
Solution Approach 2:
The system incorporates feedback mechanisms through wireless transmission of glucose data to external devices, allowing for continuous monitoring and detection of sensor drift. The feedback loop enables identification of sensor degradation patterns and can trigger alerts for sensor replacement before complete failure occurs, effectively managing the trade-off between long-term implantation and measurement accuracy.
3Volume of moving object
If the sensor is made miniaturized for less invasive implantation, then patient comfort is improved, but sensor sensitivity and detection capability are reduced
Solution Approach 1:
The patent applies local quality by concentrating the sensing function in a highly specialized, miniaturized tip or membrane region while keeping the overall sensor body compact. The sensing membrane is locally optimized with high surface area to volume ratio structures (such as porous layers or nanoscale features) that maintain high sensitivity despite the reduced overall sensor size, allowing miniaturization without sacrificing detection capability.
Solution Approach 2:
The patent replaces traditional mechanical enzyme-based sensing systems with electrochemical or optical detection methods that can be miniaturized more effectively. This substitution enables the use of microelectrodes and integrated circuits that maintain high sensitivity in miniaturized form factors, resolving the contradiction between small size and detection capability.
4Measurement precision
If oxygen-based sensing elements are used to overcome oxygen deficit, then glucose monitoring sensitivity is improved, but vascularization into the sensor membrane increases
Solution Approach 1:
The patent applies local quality by creating a spatially differentiated structure where the outer membrane has properties that deter vascularization (such as hydrophobic characteristics or specific surface energy) while the inner sensing region maintains oxygen permeability for sensitive glucose detection. This local differentiation allows the sensor to achieve high measurement precision without inducing harmful vascularization responses.
Solution Approach 2:
The sensor employs composite membrane structures combining materials with different properties - an outer layer that resists vascularization and an inner layer that permits oxygen and glucose transport. This composite approach allows the sensor to simultaneously achieve high glucose monitoring sensitivity while minimizing the harmful vascularization effect.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enables accurate and long-term blood glucose monitoring with reduced tissue response and vascularization, maintaining sensor stability and ease of explantation, thus addressing the limitations of existing sensors by providing a stable and reliable glucose monitoring system.
Implementation Method 1
a hydrophobic outer membrane to restrict blood vessel ingrowth
Implementation Method 2
permit diffusion of the analyte into the plurality of detectors
Data Source
AI summary
Biocompatible implantable sensor apparatus and methods of implantation and use. In one embodiment, the sensor apparatus is an oxygen-based glucose sensor having biocompatibility features that mitigate the host tissue response. In one variant, these features include use of a non-enzymatic membrane over each of the individual analyte detectors so as to preclude contact of the surrounding tissue with the underlying enzyme or other matrix, and mitigate vascularization, and insulation of the various electrodes and associated electrolytic processes of the sensor from the surrounding tissue. In one implementation, the sensor region of the implanted apparatus is configured to interlock or imprint the surrounding tissue so as to promote a high degree of glucose molecule diffusion into the individual detectors, and a constant and predictable sensor to blood vessel interface, yet preclude the tissue from bonding to the sensor, especially over extended periods of implant.